Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes



Status:Recruiting
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:30 - 79
Updated:12/30/2018
Start Date:May 2013
End Date:November 2019
Contact:Demetra D Christou, Ph.D
Email:ddchristou@ufl.edu
Phone:352-294-1715

Use our guide to learn which trials are right for you!

Mechanisms of Cardiovascular Dysfunction and Effect of Aerobic Exercise Training in Adults With Type 2 Diabetes

The study objectives are:

1. To compare cardiovascular function in type 2 diabetes patients vs. healthy controls.

2. To compare the effect of 8 weeks of aerobic interval training versus continuous moderate
exercise on cardiovascular function in adults with type 2 diabetes.

3. To examine the mechanisms underlying the exercise-related changes in cardiovascular
function.

The investigators hypothesize that compared to continuous moderate intensity exercise
training, interval training will be more effective in improving cardiovascular function in
adults with type 2 diabetes.

Cardiovascular function will be measured at baseline in adults with type 2 diabetes and in
age-matched healthy controls. Research volunteers with type 2 diabetes who meet the inclusion
criteria will be randomized to the aerobic interval training group, continuous moderate
exercise group or non-exercise control group. At the end of the 8-week randomized control
exercise intervention, baseline measures will be repeated.

Inclusion Criteria for type 2 diabetes :

- Diagnosis of type 2 diabetes

- Sedentary or minimally physically active for at least the prior 1 year

- Able to give consent

Inclusion criteria for healthy control group:

- Sedentary or minimally physically active for at least the prior 1 year

- Able to give consent

Exclusion Criteria:

- History of diabetic proliferative retinopathy, autonomic or peripheral neuropathy

- History of any relevant cardiovascular diseases (myocardial infarction, angina
pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart
failure, or arrhythmia)

- Hypertension (≥160 mmHg systolic or ≥100 mmHg diastolic)

- History of renal impairment

- History of gout or hyperuricemia

- History of hepatic disease or infection with hepatitis B, C

- History of seizures, or other relevant on-going or recurrent illness

- Recent (within 3 months) or recurrent hospitalizations

- Use of tobacco products

- >5 % weight change in the prior 6 months.

- Current intake of medications that may affect study results

- Premenopausal women taking oral contraceptives and postmenopausal women taking hormone
replacement therapy.

- Pregnancy (positive urine pregnancy test) or lactation

- For the healthy control group, history of diabetes.
We found this trial at
1
site
Gainesville, Florida 32610
(352) 392-3261
Principal Investigator: Demetra D Christou, Ph.D
Phone: 352-294-1715
University of Florida The University of Florida (UF) is a major, public, comprehensive, land-grant, research...
?
mi
from
Gainesville, FL
Click here to add this to my saved trials